Evaluating the Efficacy of Voice Therapy for Neurogenic Voice Disorders

Part of paid clinical trials in Austin, Texas.

Sponsor
University of Texas at Austin
Study ID
NCT07474740
Status
Active Not Recruiting

Conditions

  • Speakers With Neurogenic Voice Disorders

Eligibility Criteria

Sex
ALL
Age
18 Years - 90 Years
Healthy Volunteers
Not accepted

Interventions

  • Breathy voice — BEHAVIORAL
    Participants will be trained to produce a breathy voice to reduce the perceptual severity of vocal tremor

Study Details

The goal of this study is to evaluate the efficacy of voice therapy for neurogenic voice disorders. The main questions are: Does voice therapy improve patient-reported quality of life in speakers with neurogenic voice disorders? Does voice therapy improve listener perception of voice in speakers with neurogenic voice disorders? Does voice therapy improve acoustical analyses of voice in speakers with neurogenic voice disorders? Does voice therapy improve physiologic function in speakers with neurogenic voice disorders?

Key Dates

Start date
Jun 4, 2024
Status verified
Mar 2026
Primary completion
Jun 4, 2028
Completion
Jun 4, 2028

Study Design

Enrollment
40 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Breathy voice as a compensatory strategy for vocal tremor

Primary Outcome Measure

Patient-reported outcome measures [ Time Frame: Participants will complete ratings during the treatment phase at the beginning of the first treatment session and at the end of the last treatment session. ]

Locations (1)

FacilityCityStateZIPSite coordinators
The University of Texas at AustinAustinTexas78712-

Find similar trials in Austin, TX